Fund shareholders of Jazz Pharmaceuticals PLC
ISIN IE00B4Q5ZN47 · Ireland · LEI 635400GAUMJCLEZRRV50
- Fund shareholders
- 538
- Of which ETFs
- 133 405 other funds
- Value held
- 5B $ 2.3B SEK · 433.9K €
538 funds hold this company. This table lists the 533 that declare it in a regulatory filing. The other 5 publish their holdings in their own reports. They are not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Wilshire 5000 Index Fund Wilshire Mutual Funds Inc | 258 | 48.8K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Longview Advantage ETF RBB Fund Trust | 248 | 47.1K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| PGIM Quant Solutions Mid-Cap Index Fund Prudential Investment Portfolios 2 | 245 | 49.7K $ | 0.35 % | as of Apr 30, 2026 ↗ |
| PHARMACEUTICALS ULTRASECTOR PROFUND ProFunds | 239 | 48.5K $ | 1.44 % | as of Apr 30, 2026 ↗ |
| Destinations Shelter Fund Brinker Capital Destinations Trust | 238 | 45.2K $ | 0.05 % | as of Feb 28, 2026 ↗ |
| Hypatia Women CEO ETF Two Roads Shared Trust | 229 | 46.5K $ | 0.54 % | as of Apr 30, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) 1500 Momentum Tilt ETF SPDR SERIES TRUST | 219 | 41.4K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| HUSSMAN STRATEGIC ALLOCATION FUND Hussman Investment Trust | 200 | 37.8K $ | 0.15 % | as of Mar 31, 2026 ↗ |
| AQR CVX Fusion Fund AQR Funds | 197 | 37.2K $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Mid-Cap 1.5x Strategy Fund Rydex Series Funds | 171 | 32.3K $ | 0.26 % | as of Mar 31, 2026 ↗ |
| MID-CAP GROWTH PROFUND ProFunds | 170 | 34.5K $ | 0.71 % | as of Apr 30, 2026 ↗ |
| Disciplined U.S. Value Equity Portfolio GLENMEDE FUND INC | 170 | 34.5K $ | 1.33 % | as of Apr 30, 2026 ↗ |
| Hotchkis & Wiley SMID Cap Diversified Value Fund HOTCHKIS & WILEY FUNDS/DE/ | 133 | 25.1K $ | 1.02 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRAMID CAP ProFunds | 126 | 23.8K $ | 0.26 % | as of Mar 31, 2026 ↗ |
| MID-CAP PROFUND ProFunds | 116 | 23.6K $ | 0.25 % | as of Apr 30, 2026 ↗ |
| Xtrackers S&P MidCap 400 Scored & Screened ETF DBX ETF Trust | 108 | 20.5K $ | 0.52 % | as of Feb 27, 2026 ↗ |
| Pacer S&P MidCap 400 Quality FCF Aristocrats ETF Pacer Funds Trust | 105 | 21.3K $ | 2.16 % | as of Apr 30, 2026 ↗ |
| THRIVENT ESG INDEX PORTFOLIO Thrivent Series Fund, Inc. | 101 | 19.1K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| E*TRADE No Fee Total Market Index Fund E Trade Trust | 88 | 17.9K $ | 0.02 % | as of Apr 30, 2026 ↗ |
| Mid-Cap 1.5x Strategy Fund Rydex Variable Trust | 51 | 9.6K $ | 0.29 % | as of Mar 31, 2026 ↗ |
| SPP Generation 50-tal Storebrand Asset Management AS | 50 | 90K SEK | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Inflation Focused Equity ETF American Century ETF Trust | 42 | 8K $ | 0.09 % | as of Feb 28, 2026 ↗ |
| Sector Rotation Fund Meeder Funds | 42 | 7.9K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Mid Cap ETF Columbia ETF Trust I | 38 | 7.2K $ | 0.24 % | as of Mar 31, 2026 ↗ |
| SA Franklin Tactical Opportunities Portfolio SUNAMERICA SERIES TRUST | 37 | 7.5K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity Covington Trust | 33 | 6.2K $ | 0.06 % | as of Mar 31, 2026 ↗ |
| Fidelity Series Sustainable U.S. Market Fund Fidelity Summer Street Trust | 24 | 4.9K $ | 0.01 % | as of Apr 30, 2026 ↗ |
| Avantis Total Equity Markets ETF American Century ETF Trust | 19 | 3.6K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Goldman Sachs MSCI World Private Equity Return Tracker ETF Goldman Sachs ETF Trust | 13 | 2.5K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| VIP Hedged Equity Portfolio Variable Insurance Products Fund VI | 10 | 1.9K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| AB US Equity ETF AB Active ETFs, Inc. | 2 | 380 $ | 0.00 % | as of Feb 28, 2026 ↗ |
| SIGMA INVESTMENT HOUSE CAPITAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 238.5K € | 0.21 % | as of Dec 31, 2025 ↗ | |
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 195.4K € | 1.46 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Franklin Biotechnology Discovery Fund Franklin Strategic Series | 5.55 % | as of Apr 30, 2026 ↗ |
| Saratoga Health & Biotechnology Fund SARATOGA ADVANTAGE TRUST | 5.31 % | as of Feb 28, 2026 ↗ |
| LIVE OAK HEALTH SCIENCES FUND Oak Associates Funds | 5.25 % | as of Apr 30, 2026 ↗ |
| ROCK OAK CORE GROWTH FUND Oak Associates Funds | 4.31 % | as of Apr 30, 2026 ↗ |
| Simplify Health Care ETF Simplify Exchange Traded Funds | 4.22 % | as of Mar 31, 2026 ↗ |
| BNP Paribas Funds Health Care Innovators BNP Paribas Asset Management Luxembourg | 3.82 % | as of Dec 31, 2025 ↗ |
| Invesco Pharmaceuticals ETF Invesco Exchange-Traded Fund Trust | 3.43 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Pharmaceuticals ETF iShares Trust | 3.21 % | as of Mar 31, 2026 ↗ |
| DEAN MID CAP VALUE Unified Series Trust | 3.01 % | as of Mar 31, 2026 ↗ |
| Select Pharmaceuticals Portfolio Fidelity Select Portfolios | 2.85 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 507 | +38 | 26,057,768 | +5.9 % |
| 2026Q1 | 469 | +24 | 24,612,336 | -2.8 % |
| 2025Q4 | 445 | -22 | 25,328,443 | -4.4 % |
| 2025Q3 | 467 | -5 | 26,502,454 | +4.9 % |
| 2025Q2 | 472 | +32 | 25,254,097 | -1.5 % |
| 2025Q1 | 440 | -14 | 25,648,294 | +10.5 % |
| 2024Q4 | 454 | -23 | 23,220,696 | -7.8 % |
| 2024Q3 | 477 | -62 | 25,194,084 | +3.6 % |
| 2024Q2 | 539 | +19 | 24,321,457 | +13.6 % |
| 2024Q1 | 520 | -4 | 21,414,989 | -2.3 % |
| 2023Q4 | 524 | 21,925,690 |
Cite this page
Titelia. "Fund shareholders of Jazz Pharmaceuticals PLC". https://titelia.com/en/stocks/jazz-pharmaceuticals-plc-IE00B4Q5ZN47